Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL288516 | 0.88 | MMP1 (0.47) | MMP1MMP2MMP3MMP8LPAR3 | |
| Pyrophosphoric Acid SCHEMBL490709 | 0.88 | MMP1 (0.47) | MMP1MMP2MMP3MMP8LPAR3 | |
| Pyrophosphoric Acid SCHEMBL73402 | 0.88 | MMP1 (0.47) | MMP1MMP2MMP3MMP8LPAR3 | |
| Pyrophosphoric Acid SCHEMBL73401 | 0.88 | MMP1 (0.47) | MMP1MMP2MMP3MMP8LPAR3 | |
| Triphosphate SCHEMBL5052598 | 0.84 | MMP1 (0.44) | MMP1MMP2MMP3MMP8LPAR3 | |
| Triphosphate SCHEMBL5052601 | 0.84 | MMP1 (0.44) | MMP1MMP2MMP3MMP8LPAR3 | |
| Pyrophosphoric Acid SCHEMBL28344128 | 0.82 | LPAR3 (0.47) | MMP1MMP2MMP3MMP8LPAR3 | |
| Pyrophosphoric Acid SCHEMBL9547118 | 0.80 | LPAR3 (0.50) | LPAR3LPAR2LPAR1FDPSSMPD1 | |
| Pyrophosphoric Acid SCHEMBL9547107 | 0.80 | LPAR3 (0.50) | LPAR3LPAR2LPAR1FDPSSMPD1 | |
| Phosphoric Acid SCHEMBL310173 | 0.79 | MMP1 (0.54) | MMP1MMP2MMP3MMP8LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7348315-B2 | Methods of treating heart failure with modified ATP, ADP and AMP compounds | THE UNIVERSITY OF CONNECTICUT (US) | 2008-03-25 | — | — | US | disclosed |
| US-20030186929-A1 | Methods of treating heart failure with modified ATP, ADP and AMP compounds | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2003-10-02 | — | — | US | disclosed |
| US-6255292-B1 | INCREASING CELLULAR CONTRACTIONS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2001-07-03 | — | — | US | disclosed |
| WO-1996029345-A1 | NOVEL INOTROPIC AGENTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1996-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186929-A1 | Methods of treating heart failure with modified ATP, ADP and AMP compounds | ATP5MF, ATP5MG, ATP2A1 | MMP1 1375/4885MMP2 2045/4885MMP3 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.